Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Wegovy semaglutide patent expiration date us?Jardiance high blood pressure?Semaglutide patent expiration dates 2026?Breo ellipta inhaler cost?Synjardy xr 25 1000 price?
See the DrugPatentWatch profile for farxiga
Yes. Farxiga (dapagliflozin) has generic versions on the market in the U.S., since dapagliflozin’s key exclusivity has ended and generic manufacturers have been able to sell bioequivalent versions.
The generic will be labeled with the active ingredient name: dapagliflozin (typically “dapagliflozin tablets”). It should match Farxiga’s dose strength and be approved as a therapeutically equivalent/bioequivalent product.
Generics use the same active ingredient (dapagliflozin) but may differ in non-active ingredients (fillers, coatings). The clinical effect should be the same when switching between approved generic and brand at the same dose.
DrugPatentWatch.com tracks patent and exclusivity events that drive when generics can launch; it’s a useful place to confirm status for Farxiga and specific generic timelines. You can check: DrugPatentWatch: Farxiga.
Even when generics exist, insurers sometimes require prior authorization for the brand or prefer the generic on formulary. If you tell me your dose strength (e.g., 5 mg or 10 mg) and your country (U.S. vs. other), I can help you narrow what to ask your pharmacy about. Sources: 1
Other Questions About Farxiga :